We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current INAB market cap is 20.66M. The company's latest EPS is USD -0.4140 and P/E is -0.72.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.17M | -7.6M | -8.65M | -8.69M | -7.11M |
| Net Income | -7.17M | -7.6M | -8.56M | -8.63M | -7.09M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.07M | -8.56M | -14.65M | -28.52M | -30.34M |
| Net Income | -5.13M | -8.56M | -14.65M | -28.52M | -30.01M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 26.21M | 33.71M | 25.55M | 22.5M | 15.97M |
| Total Liabilities | 8.45M | 8.77M | 8.02M | 8.88M | 7.38M |
| Total Equity | 17.76M | 24.94M | 17.53M | 13.62M | 8.59M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.13M | 20.91M | 42.22M | 33.04M | 33.71M |
| Total Liabilities | 1.48M | 2.59M | 4.04M | 10.31M | 8.77M |
| Total Equity | -9.24M | -16.58M | 38.18M | 22.73M | 24.94M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.49M | -23.34M | -7.92M | -14.01M | -20.12M |
| Investing | -528k | -600k | -71k | -154k | -154k |
| Financing | 13.69M | 27.04M | -277k | 3.1M | 3M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.8M | -7.13M | -13.51M | -24.12M | -23.34M |
| Investing | 356k | N/A | -309k | -3.71M | -600k |
| Financing | 65k | 24.52M | 32.96M | 8.99M | 27.04M |
| Market Cap | 20.66M |
| Price to Earnings Ratio | -0.72 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.02 |
| Price to Book Ratio | 0.87 |
| Dividend Yield | - |
| Shares Outstanding | 72.48M |
| Average Volume (1 week) | 50.59M |
| Average Volume (1 Month) | 14.39M |
| 52 Week Change | -76.45% |
| 52 Week High | 1.74 |
| 52 Week Low | 0.217 |
| Spread (Intraday) | 0.02 (6.54%) |
| Company Name | IN8bio Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.in8bio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
